11-14 May 2011 Congress Dates...
Feb 25th, 2011 Deadline for early registration and accommodation...
Nov 1st, 2010 - Feb 21st, 2011 Deadline for online abstract submission...
 

May 13, 2011, Friday

TIME MEETING HALL A MEETING HALL B
08:30-10:00 Acute Lymphoblastic Leukemia
Scientific Chairs: Nicola Gökbuget (J.W. Goethe University Hospital, Frankfurt, Germany)
                               Ahmet Öztürk (Acıbadem Hospital, İstanbul, Turkey)
Speakers:
kan_damlasi What is state-of-the-art diagnosis for ALL and which information comes from new molecular markers? :   Elizabeth McIntyre (St. Louis hospital, in Paris)
kan_damlasi Management of Ph+ ALL  :  Oliver Ottmann (Universitatsklinik Frankfurt, Medizinische Klinik III, Franfurt, Germany)
kan_damlasi Management of adult ALL with risk adapted and individualised approaches:  Nicola Gökbuget (J.W. Goethe University Hospital, Frankfurt, Germany)		  
10:00 - 10:30 COFFEE BREAK  
10:30 - 12:00 Hodgkin Lymphoma
Scientific Chairs: Andreas Engert (German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany)
Mehmet Ali Özcan ( Dokuz Eylül University, İzmir, Turkey)
Speakers:
kan_damlasi Early Stages: Andreas Engert (German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany)
kan_damlasi Advanced stages: Franck Morschhauser (Service des Maladies du Sang -CHRU de Lille, Lille, France)
kan_damlasi Relapse and new drugs : Peter Borchmann (Klinik I Für Innere Medizin Universitatsklinikum, Köln, Germany)		  
12:00 - 14:00 LUNCH  
CELGENE SATELLITE SEMPOSIUM
Optimizing treatment strategies with Revlimid in Multiple Myeloma
Scientific Chair: Meral Beksaç ( Ankara University, Ankara, Turkey)
Speakers:
Michel Attal (MD Hospital Purpan, Toulouse, France)
Hakan Göker (Hacettepe University, Istanbul, Turkey)
 celgene
14:00 - 15:30 Myelodysplastic Syndromes
Scientific Chairs: H. Joachim Deeg  (Fred Hutchinson Cancer Research Center, Seattle, USA)
                               Osman İlhan (Ankara University, Ankara, Turkey)
Speakers:
kan_damlasi Old and new diagnostic approaches to MDS - Torsten Haferlach (MLL Münchner Leukämielabor GmbH, München, Germany)
kan_damlasi Treatment of low and high-risk MDS: Uwe Platzbecker (Dresden, Germany)
kan_damlasi Hematopoietic Cell Transplantation for Patients with MDS :  H. Joachim Deeg  (Fred Hutchinson Cancer Research Center, Seattle, USA)		  
15:30 - 16:00 COFFEE BREAK  
16:00 - 18:00 Infections
Scientific Chairs: Dan Engelhard (Hadassah University Hospital, Ei-Kerem, Jerusalem, Israel)
                               Ali Zahit Bolaman (Adnan Menderes University, Aydın, Turkey)
Speakers:
kan_damlasi Viruses - The invisible enemies: Per Ljungman (Karolinska University Hospital, Stockholm, Sweden)
kan_damlasi Fungi – The good, the bad  and the ugly: Catherine Cordonnier  (Henri Mondor University Hospital, Créteil, France)
kan_damlasi Bacteria - The threat of superbugs: Dan Engelhard (Hadassah University Hospital, Ei-Kerem, Jerusalem, Israel)